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        Langerhans cells (LCs) are professional APCs that 
form a dense network in the epidermis of the 
skin. LCs emigrate from the epidermis to skin 
draining LNs via the dermal lymphatics (  1  ). In the 
LNs, they display a mature phenotype and can 
pres  ent skin antigens to naive T cells (  2, 3  ). In this 
way, LCs are thought to initiate adaptive immune 
responses against the pathogenic organisms that 
are a constant challenge from the outside world. 
  One defi  ning characteristic of LCs is the 
presence of tennis racket  –  shaped intracellular 
organelles known as Birbeck granules ( 4  ). The de-
velopment of these Birbeck granules within LCs 
is dependent on the expression of the endocytic 
receptor Langerin (CD207), which is a C-type 
lectin only highly expressed on the surface of 
LCs (  5  ).   Langerin      /        mice lack Birbeck granules, 
but did not demonstrate defective immune re-
sponses, suggesting that the Langerin protein and 
Birbeck granules are dispensable for immunity 
to skin pathogens (  6  ). Despite the lack of a role 
for Langerin in skin immunity, it remains the 
best marker available for distinguishing LCs from 
other DC subtypes. 
  The role of LCs in immune responses to 
common skin pathogens and irritants is gener-
ally unclear. LCs are dispensable for the activa-
tion of T cell responses directed against HSV, 
an infection that is restricted to the epidermis. 
This was addressed using hematopoietic chimeras, 
in which it has been shown that LCs are radio-
resistant and remain of host origin for up to 1 yr 
(  7  ). In these chimeras, HSV antigens are presented 
by radiosensitive, LN-resident CD8      +   DCs, 
and not the radioresistant LCs (  8  ). In addition, 
although LCs were thought to be the primary 
APC during skin infection with   Leishmania major  , 
recent studies have shown that many other 
DC subsets, including dermal DCs and CD11b  +   
LN-resident DCs, can be infected and present 
  L. major   antigens (  9  –  12  ). In light of these fi  ndings, 
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  Langerhans cells (LCs) are antigen-presenting cells that reside in the epidermis of the skin 
and traffi  c to lymph nodes (LNs). The general role of these cells in skin immune responses is 
not clear because distinct models of LC depletion resulted in opposite conclusions about 
their role in contact hypersensitivity (CHS) responses. While comparing these models, we 
discovered a novel population of LCs that resides in the dermis and does not represent 
migrating epidermal LCs, as previously thought. Unlike epidermal LCs, dermal Langerin  +   
dendritic cells (DCs) were radiosensitive and displayed a distinct cell surface phenotype. 
Dermal Langerin  +   DCs migrate from the skin to the LNs after infl  ammation and in the 
steady state, and represent the majority of Langerin  +   DCs in skin draining LNs. Both epider-
mal and dermal Langerin  +   DCs were depleted by treatment with diphtheria toxin in   Lang-
DTREGFP   knock-in mice. In contrast, transgenic   hLang-DTA   mice lack epidermal LCs, but 
have normal numbers of dermal Langerin  +   DCs. CHS responses were abrogated upon deple-
tion of both epidermal and dermal LCs, but were unaffected in the absence of only epider-
mal LCs. This suggests that dermal LCs can mediate CHS and provides an explanation for 
previous differences observed in the two-model systems. 3148 DERMAL LANGERHANS CELLS | Bursch et al.
irradiated   Lang-EGFP   (CD45.2) host mice. The resulting chi-
meric mice were allowed to reconstitute the hematopoietic 
compartment for at least 6 wk before analysis. As expected, LCs 
within the epidermis were nearly entirely host derived (  Fig. 1 B  , 
gate a). Non-LC DCs within the LNs were almost all donor 
derived, as expected (  Fig. 1 B  , gate c). Surprisingly, given the 
host origin of LCs in the epidermis, the majority of LCs in the 
skin draining LNs were donor derived (  Fig. 1 B  , gate b). 
  The dermis contains a unique population of Langerin  +   cells 
  To better understand the origin of the donor-derived LCs, we 
analyzed cell suspensions from the dermis of the chimeric mice. 
the role of LCs in skin immune responses was further de-
bated, and it became necessary to develop better models in 
which to study LCs. 
  In an eff  ort to better study the role of LCs in immune 
responses, mouse models of LC defi  ciency were developed. 
Two groups developed knock-in mice in which LCs could be 
ablated. In these mice, the human diphtheria toxin (DT) re-
ceptor (DTR), fused to enhanced GFP (EGFP), was inserted 
into the endogenous mouse langerin locus. LCs are acutely 
depleted from these mice after DT administration (  13, 14  ). 
Another group produced LC-defi  cient mice by introduction 
of a bacterial artifi  cial chromosome (BAC) that contains the 
human Langerin locus and drives constitutive expression of 
the DTA subunit. These mice lack epidermal LCs in the skin 
from birth (  15  ). These diff  erent models provide systems in 
which the eff  ect of the absence of LCs can be determined. 
Contact hypersensitivity (CHS) is one assay used to evaluate 
cutaneous immune responses. In the acute LC ablation mice, 
one group observed decreased CHS responses in the absence 
of LCs (  14  ), whereas the other did not observe any change in 
CHS after LC depletion (  13  ). Furthermore, in the constitu-
tive LC ablation mice, CHS responses were increased, sugges-
ting a regulatory role for LCs (  15  ). The diff  erent results might 
be caused by diff  erences in CHS technique, in the cell types 
depleted in each model, or the duration of LC depletion. 
Thus, rather than defi  ning a precise role for LCs, the confl  icting 
results in LC-defi  cient mice have further obscured their role 
in initiation of immune responses to skin antigens. 
  Upon comparison of hematopoietic chimeras and the dif-
ferent mouse models of LC defi  ciency, we discovered a novel 
subset of LCs that are radiosensitive and reside in the dermis 
of the skin. This population can migrate to skin draining LNs, 
and it plays a role in the CHS response to hapten. 
    RESULTS   
  The majority of LCs in skin draining LNs are not derived 
from the epidermis 
  LCs are professional APCs in the epidermis that are distinct from 
other DCs in that they express high levels of the C-type lectin 
Langerin (  5  ). Recently, a knock-in mouse was developed in 
which the fl  uorescent protein EGFP was inserted into the 
endogenous Langerin locus (  Lang-EGFP)   (  13  ). In these mice, 
EGFP expression refl  ects expression of Langerin, and is ob-
served in two populations of DCs within skin draining LNs. 
The fi  rst population expresses low levels of Langerin, and high 
levels of CD8    , and represents blood-derived DCs that do not 
migrate from the skin (  Fig. 1 A  ) (  13  ).   The second population 
expresses high levels of Langerin and low levels of CD8    , and it 
is made up of LCs that migrate from the skin. In all further ex-
periments, we will refer only to EGFP  high  , CD8            DCs as LCs. 
  It has been shown that epidermal LCs are radioresistant and 
remain of host origin for up to 1 yr in the epidermis of lethally 
irradiated bone marrow chimeric mice (  7  ). We created bone 
marrow chimeras to address the radioresistance of diff  erent DC 
populations in skin and skin draining LNs.   Lang-EGFP.SJL   
(CD45.1) donor bone marrow was used to reconstitute lethally 
    Figure 1.         A novel population of radiosensitive LCs in dermis and skin 
draining LNs.   Bone marrow chimeric mice were created by reconstituting 
lethally irradiated   Lang-EGFP   mice with bone marrow from congenic   Lang-
EGFP.SJL   donors. (A) Representative fl  ow cytometric analysis of LN CD11c  +   
I-A  b+   DCs. A broad I-A  b+   gate was used to exclude the small number of 
non-APCs that express CD11c. The plot shows distinct populations of EGFP  -/int , 
CD8    +   DCs, and EGFP  hi   CD8         LCs. Only the latter will be referred to as 
LCs in this study. (B) Flow cytometric analysis of epidermal (a), dermal (d), and 
LN DCs (b and c) suspensions from   Lang-EGFP.SJL   into   Lang-EGFP   bone  mar-
row chimeric mice. Plots on the right show CD45.1 (donor) and CD45.2 (host) 
expression on the indicated population. A prominent population of donor-
derived LCs is observed in the LNs and dermis, but not in the epidermis.     JEM VOL. 204, December 24, 2007 
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However, the diff  erences in chimerism between dermal and 
epidermal LCs suggested that only a minority of the Langerin  +   
DCs present in the dermis could be migrating epidermal LCs. 
  In addition to   Lang-EGFP   knock-in mice, other mouse 
models have been used to study LCs. The   hLang-DTA   trans-
genic mouse was previously described by Kaplan et al., and is 
a model in which a BAC containing the human Langerin locus 
drives expression of the DT subunit A (DTA) in LCs (  15  ). 
  hLang-DTA   transgenic mice lack epidermal LCs from birth. 
We crossed   hLang-DTA   mice to   Lang-EGFP   mice to deter-
mine if all EGFP  +   LCs are ablated by the hLangerin-DTA 
transgene. No EGFP  +   cells were found in the epidermis of these 
mice (  Fig. 2 A  ).   However, EGFP  +   cells were readily detected 
in both the dermis and skin draining LNs (  Fig. 2 A  ). Again, such 
cells are not CD8    -expressing EGFP  low   cells previously de-
scribed, as they express a high level of EGFP and mouse Lan-
gerin and no CD8    . Although our results clearly indicate 
that the human Langerin BAC does not express in precisely 
The predominant cell in this tissue is a CD11b bright mono-
nuclear phagocyte, as previously concluded from immuno-
fluorescence histology analysis (  16  ). However, a distinct 
popula  tion of MHC class II  +   cells are Langerin  +   (  Fig. 1 B, 
gate d  ). Unlike in the epidermis, the majority of EGFP  +   LCs 
were of donor origin. Analysis of multiple chimeras indicated 
that epidermal LCs were 95% of host origin, but LCs found 
in the dermis and skin draining LNs were predominantly do-
nor derived (72 and 61%, respectively; Fig. S1, available at 
http://www.jem.org/cgi/content/full/jem.20071966/DC1). 
Langerin        DCs within the dermis (dermal DCs) were almost 
entirely donor derived (Fig. S1). Note that both the EGFP  low   and 
EGFP        CD8      +   DCs are also primarily bone marrow derived. 
Overall, these data suggest that a population of radiosensitive 
LCs present within the dermis may contribute to the LCs found 
in skin draining LNs. It was always presumed that dermal 
Langerin  +   cells were epidermal migrants, traffi   cking through the 
dermis to access the dermal lymphatics and migrate to the LNs. 
    Figure 2.         LCs are present in the dermis and skin draining LNs of   hLang-DTA   mice.   (A) Flow cytometry analysis of I-A  b+   CD45.2 +   cells in epidermal, 
dermal, and LN DCs suspensions from   Lang-EGFP   mice and   Lang-EGFP x hLang-DTA   Tg mice. In mice expressing the hLang-DTA transgene, EGFP  +   cells  are 
absent in epidermal cell suspensions, but present in both dermal and LN DCs preparations. Recovery of LCs in these tissues is     50  –  80% of that found in 
wild-type Lang-EGFP mice. The SD from two experiments with six   Lang-EGFP   and three   Lang-EGFP x hLang-DTA   mice is shown. (B) Immunofl  uorescence 
for Langerin and EGFP in cross sections of ear from   Lang-EGFP   mice and   Lang-EGFP   x   hLang-DTA   Tg mice reveals an absence of epidermal LCs (solid 
arrows) in   Lang-EGFP   x   hLang-DTA   Tg mice, whereas dermal Langerin  +   DCs (line arrows) are present in both strains. Bar, 75    m.  Representative  images 
from three   Lang-EGFP   and three   Lang-EGFP x hLang-DTA   mice are shown.     3150 DERMAL LANGERHANS CELLS | Bursch et al.
two populations could be further distinguished by surface 
phenotype markers. 
  Dermal Langerin  +   DCs display a distinct phenotype 
  Epidermal LCs are known to express certain phenotypic markers 
in addition to Langerin. Two important markers of epidermal 
LCs are the adhesion molecule Ep-CAM (gp40) ( 18  ) and the inte-
grin CD11b (Mac-1) (  19  ). Analysis of EGFP  +   cells from the 
dermis of   Lang-EGFP.SJL     >     Lang EGFP   chimeras revealed 
diff  erences in expression of these epidermal LC markers. 
Within the epidermis, all LCs are high for both Ep-CAM and 
CD11b (  Fig. 3 A  ).   Furthermore, in the dermis and skin drain-
ing LNs, host-derived LCs remained high for both markers. 
In contrast, donor-derived LCs were predominantly low for both 
Ep-CAM and CD11b (  Fig. 3 A  ). In addition, in   Lang-EGFP   x 
  hLang-DTA   mice that lack epidermal LCs, none of the EGFP  +   
cells present in the dermis and skin draining LNs were positive 
for Ep-CAM and CD11b (  Fig. 3 B  ). Nonchimeric   Lang-EGFP   
mice also exhibit the same two populations (unpublished data). 
This suggests that Ep-CAM and CD11b can be used to distin-
guish stable subpopulations of epidermal LCs and dermal 
Langerin  +   DCs in the steady state. 
  To provide a comprehensive analysis of phenotypic markers 
on Langerin  +   DCs, we analyzed EGFP  hi   cells from epidermis, 
dermis, and skin draining LNs (  Fig. 4  ).   Importantly, dermal 
Langerin  +   DCs (EGFP  +  , CD11b  low  ) expressed high levels of 
the same tissue-specifi  c manner as endogenous mouse Langerin, 
it conveniently provides for selective elimination of epider-
mal LCs. Thus, in the absence of migratory epidermal LCs, a 
population of LCs can be found in both dermis and skin 
draining LNs. This provides further evidence that the dermal 
Langerin  +   DC population is distinct from migrating epi-
dermal LCs. 
  Immunofl  uorescence of skin sections also indicated that 
EGFP  +   cells are absent from the epidermis, but clearly present 
in the dermis of   Lang-EGFP   x   hLang-DTA   mice (  Fig. 2 B  ). 
Within a typical skin section, epidermal LCs are more abun-
dant than dermal Langerin  +   DCs (Fig. S2 A, available at 
http://www.jem.org/cgi/content/full/jem.20071966/DC1). 
Within the dermis, we observed EGFP  +   cells both deep within 
the dermis and adjacent to hair follicles, which are lined by 
epidermis (  17  ). To distinguish epidermal LCs within hair fol-
licles from dermal Langerin  +   DCs associated with hair follicles, 
we examined   Lang-EGFP x hLang-DTA   mice that lack epi-
dermal LCs. Fig. S2 (B  –  D) shows three diff  erent sections of 
hair follicles. Clearly, dermal Langerin  +   DCs are found outside 
of the epidermis of the hair follicles (Fig. S2, B and C), al-
though in some cases they might be interdigitating within the 
follicular epidermis (Fig. S2 D). Further work will be necessary 
to determine if dermal Langerin  +   DCs have a distinct anatomi-
cal sublocation within the skin and how this may aff  ect their 
role in skin immunity. We next sought to determine if these 
    Figure 3.     Donor-derived LCs display a distinct phenotype in dermis and skin draining LNs.   Flow cytometry analysis of EGFP  +   cells in epidermal, 
dermal, and LN DC suspensions from   Lang-EGFP.SJL   into   Lang-EGFP   bone marrow chimeric mice (A) or   Lang-EGFP   x   hLang-DTA   Tg mice (B). Host-derived 
epidermal DCs are predominantly Ep-CAM  +   CD11b +  , whereas donor-derived dermal DCs are predominantly CD11b        Ep-CAM      . Data shown are represen-
tative of 12 chimeras and 6   Lang-EGFP   x   hLang-DTA   mice.   JEM VOL. 204, December 24, 2007 
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(Fig. S5, available at http://www.jem.org/cgi/content/full/
jem.20071966/DC1). The presence of these cells in   Lang-
EGFP x hLang-DTA   mice suggests that they are not related 
to epidermal LCs, which are absent in these mice. In addition, 
we found that lung Langerin  +   DCs express CD103 and do 
not express CD11b (  Fig. 4   and Fig. S4). As previously men-
tioned, the use of CD103 and CD11b allowed a clean dis-
tinction of two subsets of Langerin  +   DCs in the skin draining 
LNs (Fig. S4). In addition to lung, we were able to detect 
EGFP  +  , CD11b       , CD103  +   DCs in the liver (unpublished data). 
Altogether, our results suggest that this novel subset of Langerin  +   
DCs are present in multiple tissues, most prominent of which 
is the dermis of the skin. 
  Dermal Langerin  +   DCs migrate to skin draining LNs 
  To determine the potential for dermal Langerin  +   DCs to be 
involved in initiating immune responses to skin antigens, it 
was important to assess the ability of these cells to migrate from 
the skin to draining LNs. To test this, we applied the fl  uor-
escent dye tetramethylrhodamine-5-(and-6)-isothiocyanate 
(TRITC) to the ears of   Lang-EGFP.SJL     >     Lang-EGFP   bone 
marrow chimeric mice. TRITC  +   cells begin appearing in the 
skin draining LNs at 24 h, and were tracked until 96 h. TRITC  +   
cells were I-A  b   high, indicating that the cells were migrant DCs, 
and the dye was not transferred between cell types within 
the LNs. In addition, no TRITC  +   DCs were observed in 
nondraining LNs of TRITC-painted chimeras (  Fig. 5 A  ).   
TRITC  +   migrant DCs contained both EGFP        and EGFP  +   
DCs (  Fig. 5 B  ). TRITC  +   EGFP        cells (referred to as dermal 
DCs) were nearly all donor derived, as expected. However, 
mouse Langerin, similar to that observed on epidermal 
LCs (Fig. S3, available at http://www.jem.org/cgi/content/
full/jem.20071966/DC1). Both epidermal LCs and dermal 
Langerin  +   DCs expressed low levels of CD40, MHC II (I-A  b  ), 
and the costimulatory molecule CD86 (B7-2) in the tissue, but 
increased levels in the skin draining LNs (  Fig. 4  ). Interestingly, 
some cell surface molecules, such as Dectin-1 and Ep-CAM, 
were highly expressed on epidermal LCs, but were absent or 
low on dermal Langerin  +   DCs, both in the tissue and in the 
draining nodes (  Fig. 4  ). Other molecules, such as CD103, 
were observed on dermal, but not epidermal LCs, and this 
was also preserved in the draining nodes. Expression of all 
analyzed markers on EGFP  +  CD11b  +   cells in the dermis was 
similar to that of epidermal LCs (unpublished data), which is 
consistent with these cells being migrating epidermal LCs. 
We conclude that Langerin  +   DCs in the dermis are com-
prised of both migratory epidermal and dermal populations 
that display distinct phenotypes. In this regard, we note that 
the combination of CD103 and CD11b provides a nice dis-
tinction of these two populations within Langerin  +   DCs in 
the skin draining LNs (Fig. S4, available at http://www.jem
.org/cgi/content/full/jem.20071966/DC1). 
  LCs with a similar phenotype reside in other tissues 
  It has been reported that a subset of CD103 (    E)-    7 integrin  +   
and CD11b        DCs within the lung express langerin (  20  ). We 
analyzed lung tissue from   Lang-EGFP   and   Lang-EGFP x 
hLang-DTA   mice to determine if these cells were present in these 
mouse models. We identifi  ed EGFP  +  CD8            LCs in lung tis-
sue of both   Lang-EGFP   and   Lang-EGFP x hLang-DTA   mice 
    Figure 4.     Dermal Langerin  +   DCs express different levels of costimulatory and adhesion molecules.   DCs were harvested from epidermis, dermis, 
lung, and skin draining LNs (SDLN) of 4   Lang-EGFP   animals.  CD11c +   populations were enriched from lung and LNs using MACS. Total EGFP  +   cells  are 
shown for epidermis and lung. In dermis and skin draining LNs, epidermal LCs and dermal Langerin  +   DCs were distinguished using CD103 and CD11b as 
shown in Fig. S4. Isotype control staining is shown in the shaded histograms. Data are representative of two to six experiments. Fig. S4 is available at 
http://www.jem.org/cgi/content/full/jem.20071966/DC1.   3152 DERMAL LANGERHANS CELLS | Bursch et al.
epidermis and skin draining LNs. It was previously shown in 
these mice that EGFP  +   LCs reappeared in the LNs before re-
appearing in the epidermis of the skin (  13  ). We reasoned that 
EGFP  +   cells present in the LNs before the return of epidermal 
LCs might be dermal Langerin  +   DCs. Importantly, dermal 
Langerin  +   DCs express similar levels of EGFP and murine 
Langerin, making these cells equally sensitive to toxin treatment. 
We administered DT and assessed the return of EGFP  +   LCs 
in epidermis, dermis, and skin draining LNs at intervals for up 
to 2 wk. At day 2 after toxin treatment, LCs were depleted 
(  >  90% reduction) in all tissues. By day 3 after toxin, LCs were 
returning to the dermis, and continued to increase in frequency 
over the next 2 wk. LCs did not return to the skin draining 
LNs within the fi  rst 4 d, but were observed at day 7 after DT. 
Despite return of LCs to both dermis and skin draining LNs, 
LC return in the epidermis was not observed throughout the 
time course (  Fig. 6 A  ), which is consistent with previous stud-
ies (  13, 14  ).   These data provide further correlative evidence 
that dermal Langerin  +   DCs can migrate to skin draining LNs 
in the steady state. Importantly, the distinct timing of return 
of dermal Langerin  +   DCs and epidermal LCs after toxin treat-
ment provided a window in which to assess their relative roles 
in CHS responses. 
  It was originally reported that toxin treatment does not 
impair CHS in   Lang-DTREGFP   mice when DT is adminis-
tered 3 d before and 1 d after sensitization (  13  ). However, we 
recently determined that LC depletion in   Lang-DTREGFP   
mice can reduce CHS responses if the DT is administered 1 d 
before sensitization with the dinitrofl  uorobenzene (DNFB) 
hapten (unpublished data). This depletion strategy provides 
for ablation of both dermal Langerin  +   DCs and epidermal 
LCs, without return of either population at the time of sensi-
tization. We took advantage of the diff  erential time course of 
Langerin  +   DC return, and administered toxin at either 1 d 
before sensitization, for depletion of both dermal Langerin  +   
DCs and epidermal LCs, or 7 or 13 d before sensitization for 
depletion of only epidermal LCs. CHS responses, as measured 
by swelling on the challenged ear, were unaff  ected by toxin 
administration at 7 or 13 days before sensitization. However, 
CHS was substantially inhibited by toxin administration 1 d 
before sensitization (  Fig. 6 B  ). Our results show that Langerin  +   
cells in general are necessary for an optimal CHS response. 
Furthermore, they are consistent with the notion that dermal 
Langerin  +   DCs, specifi  cally, can promote this response in the 
absence of epidermal LCs. 
    DISCUSSION   
  A novel population of LCs 
  We have identifi  ed a novel population of LCs that are distinct 
from the traditional epidermal LCs. This novel population is 
bone marrow derived in hematopoietic chimeras, whereas 
epidermal LCs are radioresistant and remain of host origin (  7  ). 
This LC population is also anatomically distinct, as it occupies 
the dermis of the skin and is not present in the epidermis. 
Phenotypically, the dermal Langerin  +   DC population is distinct 
from epidermal LCs in its expression of CD11b, Ep-CAM, 
TRITC  +   LCs were also predominantly donor derived (  Fig. 5 B  ). 
The presence of a high frequency of donor-derived LCs 
suggests that radiosensitive dermal Langerin  +   DCs can mi-
grate from TRITC-painted skin. Application of TRITC is 
known to induce infl  ammation within the skin, and can in-
crease migration of epidermal LCs. It was previously shown 
in   Lang-EGFP   mice that migration of EGFP  +   LCs peaks at 
96 h after TRITC painting (  13  ). We observed that at early 
time points (48/72 h) TRITC  +   LCs were predominantly do-
nor derived. However, at 96 h, host-derived LCs comprised 
almost half of the TRITC  +   LCs in the LNs (  Fig. 5 C  ). These 
re  sults are consistent with early migration of both dermal 
DCs and dermal Langerin  +   DCs, and a later migration of epi-
dermal LCs. 
  Dermal Langerin  +   DCs play a role in CHS responses 
  Given the diff  erences in phenotype, anatomical location, and 
migration kinetics, we sought to determine if dermal Langerin  +   
DCs and epidermal LCs might have unique functions in 
immune responses. In this regard, both CD11b  +   (epidermal) 
and CD103  +   (dermal) langerin  +   DCs isolated from skin drain-
ing LNs were able to stimulate T cell proliferation when pulsed 
with peptide antigen (Fig. S6, available at http://www.jem
.org/cgi/content/full/jem.20071966/DC1). To examine skin 
immune responses specifi  cally, we used the CHS assay. We used 
another Langerin knock-in mouse to test the function of dis-
tinct LC subsets in CHS in vivo.   Lang-DTREGFP   knock-in 
mice express the human DTR fused to EGFP under the control 
of the endogenous murine Langerin promoter. Administration 
of DT to   Lang-DTREGFP   mice results in ablation of LCs in 
    Figure 5.         Donor-derived LCs migrate from the skin to draining LNs.   
  Lang-EGFP.SJL   into   Lang-EGFP   bone marrow chimeras were painted 
with TRITC on the ear, and draining nodes were analyzed at 48, 72, or 
96 h. (A) Dot plots show the fraction of TRITC  +   CD11c +   DCs in draining 
(top) or nondraining (bottom) LNs after 72 h. (B) The histogram (left) 
shows Langerin (EGFP) expression on the migrated (TRITC  +  ) DCs in the 
LNs at 72 h. The bar graph (right) shows the mean percentage of donor- 
(CD45.1  +  ) or host-derived (CD45.2  +  ) cells among migrated LCs (EGFP  + ) 
and other DCs (EGFP       ). Error bars indicate the SD. (C) Relative percentage 
of host- and donor-derived EGFP  +   LCs in skin draining LNs over time 
(mean   ±   the SD) shown for three mice at each time point.     JEM VOL. 204, December 24, 2007 
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CCR7 for entry into dermal lymphatics and traffi   cking to 
draining LNs (  23  ). Although it is possible that dermal Langerin  +   
DCs are derived from the same monocyte precursor that has 
been shown to give rise to epidermal LCs (  21  ), this has not 
been shown. If this is the case, it is also interesting that in the 
absence of an infl  ammatory signal, these LC precursors give rise 
to dermal Langerin  +   DCs, but not epidermal LCs, as shown 
after depletion of these two subsets with DT administration in 
  Lang-DTREGFP   mice. Additional studies will be needed to 
determine the ontogeny of dermal Langerin  +   DCs, and their 
relationship to epidermal LCs. 
  Reconciliation of data from different models 
of LC depletion 
  Three diff  erent models of LC depletion have been described 
and used to test the role of LCs in CHS responses. Two of these 
models (  Lang-DTREGFP  ) are knock-in mice in which the 
human DTR is expressed under the control of the endog-
enous mouse langerin promoter (  13, 14  ). The third model 
(  hLang-DTA  ) is a BAC transgenic mouse in which DTA is ex-
pressed under the control of the human langerin promoter (  15  ). 
Disappointingly, these models all came to diff  erent conclu-
sions about the role of LCs in CHS responses. The knock-in 
mice displayed reduced or unchanged CHS after LC depletion, 
and the BAC transgenic mice had enhanced CHS in the 
absence of LCs. We presume that the first two models are 
equivalent, as we have shown a decrease in CHS when LCs 
were depleted 1 d before sensitization of the mice with DNFB 
(unpublished data). We show that the timing of depletion is 
critical for observing decreased CHS, presumably because an 
additional population of dermal Langerin  +   DCs is returning 
to the skin as little as 3 d after DT administration. The presence 
of the dermal Langerin  +   DC population was not appreciated 
in previous interpretation of these results. Therefore, we propose 
that LCs in general are required for maximal CHS responses, 
but nonepidermal Langerin  +   DCs can mediate the CHS re-
sponse in the absence of epidermal LCs. We also show that 
dermal Langerin  +   DCs are not depleted in   hLang-DTA   mice, 
and are therefore likely to mediate CHS in these mice despite 
the absence of epidermal LCs. 
  From the available data, it appears that epidermal LCs are 
not strictly required for CHS. However, they can present anti-
gen and migrate to skin draining LNs. Given their late migra-
tion kinetics, relative to dermal DCs, it is tempting to speculate 
that they serve a negative regulatory function. We did not ob-
serve a substantial increase in CHS at the 13-d time point when 
dermal Langerin  +   cells have returned, but epidermal LCs have 
not (  Fig. 6  ). Thus, our results do not explain the enhancement 
of CHS responses observed in   hLang-DTA   mice. It is possible 
that hLang-DTA mice display enhanced CHS as a result of 
chronic (lifelong) LC defi  ciency. Further experiments with 
these model systems will be necessary to address this question. 
  The biological role of dermal Langerin  +   DCs 
  It is clear from our studies that dermal Langerin  +   DCs are ca-
pable of participating in skin immune responses. However, it 
Dectin-1, and CD103 (      E  )-      7   integrin. Other potential dif-
ferences between these subsets could be revealed through 
microarray analysis of sorted populations of dermal Langerin  +   
DCs and epidermal LCs. We have also identifi  ed these cells in 
the lung and liver, suggesting that they are, in fact, a subset of 
interstitial DCs found throughout the body. 
  Dermal Langerin  +   DCs can traffi   c from the skin to drain-
ing LNs both in the steady state and after the application of 
TRITC to the skin. We cannot rule out that these cells can also 
arrive in the LNs via the blood, but we think it is unlikely, as 
we do not observe EGFP  +   cells in the blood of   Lang-EGFP   mice. 
It is probable that these cells have requirements for migration 
from skin that are similar to epidermal LCs and other DCs. 
Entry of monocyte precursors, which can give rise to epidermal 
LCs, has been shown to require CCR2 and CCR6 (  7, 21  ). 
Although it is likely that dermal Langerin  +   DC precursors 
require CCR2 for entry into the dermis, it is less likely that 
they require CCR6, which is necessary for entry into the 
epidermis (  22  ). It seems likely that all DCs would require 
    Figure 6.     Dermal Langerin  +   DCs contribute to the CHS response.  
(A) Time course of LC recovery in various tissues.   Lang-DTREGFP   mice 
were treated with 1     g DT i.p. on day 0. The recovery of EGFP  +   LCs  in 
epidermis, dermis, and skin draining LNs was determined 2, 3, 4, 7, or 13 d 
later. The graph shows percentage of LC return, calculated as the percent-
age of EGFP  +   DCs at the time of analysis compared with untreated control 
mice (mean  ±   the SD) for three mice/group. (B) CHS.   Lang-DTREGFP   mice 
were treated with 1     g DT i.p. at 1, 7, or 13 d before sensitization on the 
fl  ank with DNFB. Mice were challenged with DNFB on the ear 5 d later, 
and ear swelling was measured 24 h after challenge. Positive control mice 
were not DT treated, and received both sensitization and challenge doses. 
Negative control mice were not sensitized, but received the challenge 
dose. Experimental results are shown from three independent experi-
ments. The P value for specifi  c comparisons is shown.     3154 DERMAL LANGERHANS CELLS | Bursch et al.
  Radiation bone marrow chimeras.     Single-cell suspensions of bone mar-
row were prepared and depleted of mature T cells by complement-mediated 
cytotoxicity with 30H12 (anti-Thy1.2; American Type Culture Collection), 
as previously described (  28  ). Bone marrow cells were injected i.v. (5   ×   10  6   
cells/recipient) into lethally irradiated recipient mice (1000 rads). Hemato-
poietic chimerism in skin and lymphoid organs was determined by staining 
with anti-CD45.2 and -CD45.1 antibodies for fl  ow cytometry analysis. 
  DC preparation from LNs.     DCs from skin draining LNs and lung were 
prepared by digestion with collagenase D (Sigma-Aldrich) and EDTA, as 
previously described (  29  ). LN suspension cells were then labeled using MACS 
anti-CD11c MicroBeads (Miltenyi Biotech) and passed over a magnetized 
MACS LS selection column. After washing of the magnetized column, CD11c  +   
DCs were collected from the column. 
  Preparation of epidermal and dermal cell suspensions.     Epidermal and 
dermal cell suspensions were prepared from both ear and fl  ank skin. Epider-
mal cells were prepared by limited trypsinization and dissociation of epider-
mal sheets by pipetting in DNase, as previously described (  30  ). Dermal cells 
suspensions were prepared from skin after the removal of the epidermis. Dermal 
tissue was minced into small pieces and digested for 2 h at 37  °  C with a solu-
tion of RPMI  +   10 mM Hepes  +   0.05% DNase I (Sigma-Aldrich), 0.27% col-
lagenase type XI (Sigma-Aldrich), and 0.027% hyaluronidase type IV-S 
(Sigma-Aldrich). The absence of epidermal contamination within the dermal 
cell suspension was confi  rmed by fl  ow cytometry for dendritic epidermal T 
cells using an anti-        TCR antibody (GL3; BD Biosciences). Alternatively, 
for preservation of trypsin-sensitive epitopes, whole skin was minced and di-
gested as described in the previous section. Dermal Langerin  +   cells were iden-
tifi  ed after this digestion by expression of CD103. 
  Antibodies and fl  ow cytometry.     Fluorochrome-conjugated antibodies to 
CD11c, I-A  b  , CD11b, CD8    , CD45.1, CD45.2, and CD103, and biotinyl-
ated antibodies to CD103, CD40, and CD86 were purchased from eBiosci-
ence, BD Biosciences, or BioLegend. Biotinylated antibody to Dectin-1 was 
purchased from AbD Serotec. Streptavidin-APC obtained from eBioscience 
or Streptavidin-PerCP obtained from BD Biosciences was used as a second-
ary antibody with biotinylated antibodies. The anti  –  Ep-CAM antibody was 
purifi  ed from G8.8 hybridoma supernatant (obtained from A. Farr, University 
of Washington, Seattle, WA), and biotinylated. Purified anti-mLangerin 
antibody (929F3) was purchased from AbCys (and is now available from 
Dendritics), and goat anti  –  rat IgG (BD Biosciences) was used as the second-
ary antibody. For intracellular staining of mLangerin, cells were fi  xed and 
permeabilized using the BD Cytofi  x/Cytoperm kit (BD Biosciences). All data 
were collected on a BD LSR II fl  ow cytometer and analyzed with FlowJo 
software (Tree Star, Inc.). 
  Sorting DC subsets and in vitro stimulation.     DC subsets were sorted 
after enrichment for CD11c  +   cells by MACS (Miltenyi Biotech), using a 
FACSAria instrument in the Cancer Center Flow Cytometry Core Facility. 
CD8      +   DCs were sorted as a control population for the stimulation. EGFP  +   
cells were sorted into dermal Langerin  +   DCs (CD103  +  CD11b       ) or epider-
mal LCs (CD103       CD11b  +  ). Sorted subsets were incubated with SIINFEKL 
peptide at 10-fold dilutions for 1 h at 37  °  C, and washed 2 times with media. 
OT-I CD8 T cells were purifi  ed from LN cell suspensions and purifi  ed by 
negative selection using MACS (Miltenyi Biotech). FITC-coupled anti-
bodies to B220, I-Ab, CD4, and CD44 (BD Biosciences or eBioscience) 
were used, followed by anti-FITC MicroBeads (Miltenyi Biotech). Purifi  ed 
cells were   >  90% OT-I and were subsequently CFSE labeled; 10  4   DCs from 
each sorted subset were incubated at 37  °  C with 5   ×   10  4   purifi  ed CFSE-
labeled OT-I T cells. CFSE dye dilution was measured after 65 h. 
  Immunofl  uorescence.     Whole ears were fi  xed in 4% paraformaldehyde in 
PBS overnight, rinsed with PBS, and infi  ltrated with 15% sucrose/PBS over-
night at 4  °  C. The medium was changed for 7.5% gelatin containing 15% 
sucrose at 37  °  C for 2  –  4 h, and the tissues were rapidly frozen at     40  °  C in 
is not clear if these cells play a role in other responses, includ-
ing infection. It has recently been shown that gene gun 
immunization is not aff  ected by depletion of LCs in   Lang-
DTREGFP   mice (  24  ). We have also observed that LCs are not 
required for epicutaneous immunization in the presence 
of an adjuvant (unpublished data). In these situations, it is 
likely that dermal DCs are capable of mediating the response, 
or that infl  ammation within the skin leads to recruitment of 
additional infl  ammatory APCs that can induce T cell responses 
after migration to LNs. The ability of dermal Langerin  +   DCs 
to provide a function in CHS that is not redundant with other 
dermal DCs is surprising, given their anatomical location 
within the dermis. However, we observed the clustering of 
these cells around the hair follicles within the dermis. This 
may provide dermal Langerin  +   DCs better access to antigens 
that do not penetrate deep within the dermis. Alternatively, 
their functional properties may be related to their expression 
of Langerin. Langerin is known to bind some virus particles, 
and it was shown that HIV-1 virus captured by Langerin was 
internalized into Birbeck granules and degraded (  25  ). We do not 
know whether dermal Langerin  +   DCs display the characteristic 
Birbeck granules that distinguish epidermal LCs (  4  ). However, 
the production of these organelles is dependent on Langerin 
expression (  6, 26  ), which is expressed at similar levels in dermal 
Langerin  +   DCs and epidermal LCs. 
  Given the observation that these cells are present in the 
lung, and are important in immune responses, it will be inter-
esting to examine their role in immune responses within the 
lung. A previous study identifi  ed a population of DCs that 
migrated from the lung and presented viral antigens during 
infl  uenza infection (  27  ). Additional phenotyping of these 
migratory lung DCs will be needed to determine if they are, 
indeed, the lung Langerin  +   DC subset we have identifi  ed in 
  Lang-EGFP   mice. 
  Our study has identifi  ed a novel population of LCs that 
resides in the dermis of the skin and the lung. This subset is 
distinct from epidermal LCs, and is capable of contributing to 
skin immune responses. Identifi  cation of this subset provides 
reconciliation of previous data examining the role of LCs in 
CHS responses, and insight into the complexity of immune 
responses to antigens within the skin. These cells should be 
considered when addressing the role of LCs using any of the 
models of LC depletion. The immune stimulatory capability 
of this population also provides another component of the im-
mune system that could be targeted for vaccine development. 
    MATERIALS AND METHODS   
  Mice.     C57BL/6 (B6) and congenic B6.SJL  CD45.1   mice were purchased from 
the National Cancer Institute.   Lang-EGFP   and   Lang-EGFPDTR   knock-in 
mice were previously described (  13  ), and they were bred to each other to 
yield mice heterozygous for each knock-in allele.   Lang-EGFP   mice were also 
bred to B6.SJL  CD45.1   mice to produce   Lang-EGFP.SJL   mice for chimeras. 
  hLang-DTA   mice (  15  ) were backcrossed to B6 for 9 generations and bred to 
  Lang-EGFP   mice to produce mice heterozygous for both the EGFP Langerin 
knock-in reporter and the hLangerin-DTA transgene. All mice were treated 
in accordance with federal guidelines, and protocols were approved by the 
University of Minnesota Institutional Animal Care and Use Committee. JEM VOL. 204, December 24, 2007 
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isopentane (Sigma-Aldrich). Frozen sections were cut at 8     m and collected 
on poly-  l  -lysine  –  coated slides. Cryostat sections were stained for EGFP and 
langerin, as follows. After rehydration in PBS, sections were incubated with 
FITC-conjugated anti-GFP (Rockland Immunochemicals, Inc.) and anti-
langerin antibodies (clone: L31; a gift from R. Steinman, The Rockefeller 
University, New York, NY) (  31  ) for 1 h, followed by anti-FITC  –  Alexa Fluor 
488 (Invitrogen) and anti  –  rat IgG-Alexa Fluor 546 (Invitrogen). The nuclei were 
stained with DAPI (Invitrogen). Images were captured using a microscope 
(DM5500; Leica) with digital system and LAS AF software (version 1.5.1). 
  TRITC painting.     TRITC was purchased from Invitrogen and prepared at 
a 10% stock in DMSO. Stock TRITC was diluted to 1% in a 1:1 mix of 
acetone and dibutylphthalate for painting. 10     l of 1% TRITC solution was 
applied per ear, to both the dorsal and ventral sides. 
  LC depletion with DT.     LCs were systemically depleted in   Langerin-
DTREGFP   mice by i.p. injection of 1     g DT (List Biological Laboratories), 
as previously described (  13  ). 
  CHS.     All mice were shaved at least 1 d before immunization. 25     l of 0.3% 
DNFB (Sigma-Aldrich) in a mixture of acetone and olive oil (4:1) was painted 
on the back fl  ank of the mice. On day 5, all mice were challenged with 5   μ  l of 
0.15% DNFB on both sides of one ear. Ear thickness was measured before and 
24 h after challenge, with a spring-loaded micrometer (Mitutoyo). 
  Online supplemental materials.     Fig. S1 shows that LCs in the dermis and 
skin draining LNs are predominantly donor derived in bone marrow chimeric 
mice. Fig. S2 shows dermal Langerin  +   DCs in relative frequency and anatomi-
cal location. Fig. S3 displays the expression of mLangerin on epidermal LCs 
and dermal Langerin  +   DCs. Fig. S4 demonstrates the expression of CD103 and 
CD11b on EGFP  +   cells in diff  erent tissues. Fig. S5 demonstrates the presence 
of Langerin  +   DCs in the lung that display a similar phenotype to dermal Lan-
gerin  +   DCs. Fig. S6 shows the stimulation of OT-I T cells by pulsed epidermal 
LCs and dermal Langerin  +   DCs. The online version of this article is available at 
http://www.jem.org/cgi/content/full/jem.20071966/DC1. 
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